Glucose News and Research

RSS

Study provides new insights for the future development of oral insulin pill

WEHI researchers in Melbourne have answered a 100-year-old question in diabetes research: can a molecule different to insulin have the same effect? The findings provide important insights for the future development of an oral insulin pill.

12 Dec 2022

Complementary, alternative therapies for heart failure have some benefits and potential risks

There are some benefits and potentially serious risks when people with heart failure use complementary and alternative medicines (CAM), to manage symptoms, so involving the health care team is important for safety, according to a new American Heart Association scientific statement published today in the Association's flagship, peer-reviewed journal Circulation.

8 Dec 2022

Addition of yoga to regular exercise training supports cardiovascular health and wellbeing

A three-month pilot study of patients with hypertension appearing in the Canadian Journal of Cardiology, published by Elsevier, demonstrates that adding yoga to a regular exercise training regimen supports cardiovascular health and wellbeing and is more effective than stretching exercises.

8 Dec 2022

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Researchers evaluated individuals who had SARS-CoV-2 infections and were diagnosed with diabetes mellitus within six months of the onset of COVID-19 to understand the temporal relationship between SARS-CoV-2 infections and diabetes mellitus.

8 Dec 2022

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society.

7 Dec 2022

Study allows people with type 2 diabetes to choose their own medication

A large-scale new study offers a new approach to treating type 2 diabetes - that puts patients in charge of their own medication. The Trimaster study is the first to allow people with type 2 diabetes to choose their own medication, after trying three different drugs in succession.

7 Dec 2022

Colorado option’s big test: Open enrollment

Critics declared Colorado's new quasi-public option a failure this fall, before it was even available for purchase on the state's Affordable Care Act health insurance marketplace.

7 Dec 2022

Gestational diabetes mellitus linked to early particulate matter exposure with high BMI

Researchers assess the impact of high BMI before pregnancy, coupled with exposure to different levels of PM, on the incidence of gestational diabetes.

6 Dec 2022

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Teens with Type 1 diabetes (T1D) who took bromocriptine, a medication used to treat Parkinson's disease and Type 2 diabetes, had lower blood pressure and less stiff arteries after one month of treatment compared to those who did not take the medicine, according to a small study published today in Hypertension, an American Heart Association journal.

6 Dec 2022

Klick scientists use machine learning and 12 hours of CGM data to predict diabetes onset

Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.

2 Dec 2022

Novel biosensor enhances performance of home-based continuous glucose monitoring

Home-based continuous glucose monitoring for diabetics up to now has had to trade ease of use, low cost, and portability for a somewhat lower sensitivity - and thus accuracy - compared to similar systems in clinics or hospitals.

2 Dec 2022

Researchers develop a self-powered ingestible sensor system to monitor intestinal metabolites

Engineering researchers have developed a battery-free, pill-shaped ingestible biosensing system designed to provide continuous monitoring in the intestinal environment.

1 Dec 2022

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Very low-calorie diets and vegan diets improve weight loss and anthropometric markers in type 2 diabetes patients.

1 Dec 2022

Early life experiences can affect gene activity more than half a lifetime later

Early life experiences can impact the activity of our genes much later on and even affect longevity, finds a new study in fruit flies led by UCL researchers.

1 Dec 2022

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that high glucose impairs the antitumor activity of immune effector γδ-T cells, which contributes to the increased cancer risk in diabetes and that metabolic reprogramming by glucose control may improve the antitumor activity of γδ-T cells.

30 Nov 2022

SARS-CoV-2 can cause hyperglycemia in cats

In a recent study published in The Journal of Infectious Diseases, researchers explored the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hyperglycemia in cats.

30 Nov 2022

Meta-analysis reviews the incidence of new-onset diabetes in COVID-19 survivors

Researchers estimated the incidence of new-onset diabetes in survivors of coronavirus disease 2019 (COVID-19) employing random-effects meta-analyses using the generic inverse variance method.

30 Nov 2022

Comparing Mediterranean diet versus low-fat diet for metabolic syndrome

Researchers assess the impact of the Mediterranean diet in comparison to a low-fat diet on the outcomes of metabolic syndromes.

29 Nov 2022

Consultation on insurance issues and training needed to improve the use of continuous glucose monitoring in primary care

Continuous glucose monitoring (CGM) is associated with improved health outcomes for patients with diabetes.

29 Nov 2022

Endogenous system may be responsible for delayed onset of diabetic retinopathy

About one third of patients with diabetes mellitus (DM) develop diabetic retinopathy (DR), a leading cause of blindness in working-age individuals. DR typically develops after many years of DM, and some patients do not develop DR for more than 50 years.

29 Nov 2022

Glucose News and Research

Study provides new insights for the future development of oral insulin pill

Complementary, alternative therapies for heart failure have some benefits and potential risks

Addition of yoga to regular exercise training supports cardiovascular health and wellbeing

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

New Clinical Practice Guideline offers recommendations to manage hypoglycemia in people with diabetes

Study allows people with type 2 diabetes to choose their own medication

Colorado option’s big test: Open enrollment

Gestational diabetes mellitus linked to early particulate matter exposure with high BMI

Parkinson’s drug improves blood pressure, aortic stiffness in adolescents with Type 1 diabetes

Klick scientists use machine learning and 12 hours of CGM data to predict diabetes onset

Novel biosensor enhances performance of home-based continuous glucose monitoring

Researchers develop a self-powered ingestible sensor system to monitor intestinal metabolites

Very low-calorie and vegan diets improve glycemic control in type 2 diabetes

Early life experiences can affect gene activity more than half a lifetime later

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

SARS-CoV-2 can cause hyperglycemia in cats

Meta-analysis reviews the incidence of new-onset diabetes in COVID-19 survivors

Comparing Mediterranean diet versus low-fat diet for metabolic syndrome

Consultation on insurance issues and training needed to improve the use of continuous glucose monitoring in primary care

Endogenous system may be responsible for delayed onset of diabetic retinopathy

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News